A
Allgens Medical Technology Co Ltd
SSE:688613
Allgens Medical Technology Co Ltd
SSE:688613
Price:
20.86
CNY
6%
Market Closed
Market Cap:
¥2.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Allgens Medical Technology Co Ltd
SSE:688613
|
CN |
Relative Value
The Relative Value of one Allgens Medical Technology Co Ltd stock under the Base Case scenario is 12.63 CNY. Compared to the current market price of 20.86 CNY, Allgens Medical Technology Co Ltd is Overvalued by 39%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
12.63
CNY
Overvaluation 39%
A
Multiples Across Competitors
Competitors Multiples
Allgens Medical Technology Co Ltd Competitors
Allgens Medical Technology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
A
|
Allgens Medical Technology Co Ltd
SSE:688613
|
2.9B CNY | 14.2 | -154 | -91.4 | -91.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182B USD | 4.1 | 27.9 | 16 | 22 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.9B USD | 16.6 | 58.4 | 44.3 | 54.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.7B USD | 5 | 38.6 | 19.8 | 23.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.8B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.5B USD | 5.2 | 35.7 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.7 | 11.1 | 15.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD | 7.9 | 44.8 | 24.6 | 27 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.9B USD | 10.7 | 43.3 | 30.7 | 34 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.1B USD | 2.1 | 25.7 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
